Tempest Therapeutics, Inc. Common Stock TPST

$0.38 -3.53% at last close

Recent SEC Filings

FormDescriptionFiledDocument
8-K CURRENT REPORT 2026-11-12 View →
8-K CURRENT REPORT 2026-11-10 View →
8-K CURRENT REPORT 2026-11-06 View →
4 OWNERSHIP DOCUMENT 2026-11-02 View →
8-K CURRENT REPORT 2026-10-30 View →
DEF 14A DEFINITIVE PROXY STATEMENT 2026-10-26 View →
8-K CURRENT REPORT 2026-10-20 View →
8-K CURRENT REPORT 2026-10-19 View →
4 Insider transaction 2026-10-02 View →
8-K CURRENT REPORT 2026-09-28 View →
S-3 REGISTRATION STATEMENT 2026-09-25 View →
8-K 8-K 2026-09-17 View →
8-K 8-K 2026-09-16 View →
8-K 8-K 2026-09-15 View →
8-K 8-K 2026-08-24 View →
S-1 S-1 2026-08-21 View →
8-K 8-K 2026-08-18 View →
10-Q 10-Q 2026-08-13 View →
8-K 8-K 2026-08-13 View →
8-K 8-K 2026-08-13 View →
8-K 8-K 2026-07-28 View →
8-K 8-K 2026-07-22 View →
DEF 14A DEF 14A 2026-07-17 View →
S-3 S-3 2026-06-26 View →
4 4 2026-06-23 View →
8-K 8-K 2026-06-23 View →
4 4 2026-06-17 View →
4 4 2026-06-08 View →
DEF 14A DEF 14A 2026-06-08 View →
8-K 8-K 2026-06-04 View →
8-K 8-K 2026-06-02 View →
8-K 8-K 2026-05-29 View →
8-K 8-K 2026-05-22 View →
8-K 8-K 2026-05-22 View →
10-Q 10-Q 2026-05-14 View →
8-K 8-K 2026-05-14 View →
8-K 8-K 2026-05-06 View →
4 Insider transaction 2026-04-02 View →
4 Insider transaction 2026-04-02 View →
S-3 S-3 2026-04-02 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$0.38
Market Cap
$7.66 million
52-Week Range
$0.34 – $12.23
Average Volume
279K shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.